Bill Snyder

A broad and diverse group of 150 Medical Center and University leaders, students, and community stakeholders met Monday afternoon at the Vanderbilt Student Life Center to advance Vanderbilt University Medical Center’s Strategy Framework process. Read More

Research in the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) aimed at developing innovative new treatments for schizophrenia just received a powerful assist from The William K. Warren Foundation. Read More

The National Institutes of Health (NIH) has awarded a major renewal grant to continue the National Research Resource for Imaging Mass Spectrometry at Vanderbilt University School of Medicine. Read More

Increasing expression of a transcription factor called KLF2 can promote immunological self-tolerance and “tune down” autoimmunity, researchers at Vanderbilt University Medical Center reported recently. Read More

Using an antibody generated at Vanderbilt University Medical Center that neutralizes the Ebola virus, researchers at the Scripps Research Institute in La Jolla, California, have determined the structure of a “decoy” protein that may enable the virus to evade detection by the immune system. Read More

With the theme of “It’s About People,” Jeff Balser M.D., Ph.D., President and CEO of Vanderbilt University Medical Center and Dean of Vanderbilt University School of Medicine, began the Summer Clinical Enterprise Leadership Assembly by urging nearly 1,000 Medical Center leaders in attendance in Langford Auditorium to consider the emotional needs of members of their teams. In particular, he asked leaders to recognize the psychological impact of recent tragic events happening across the U.S. and in other nations. Read More

Hypoxia (lack of enough oxygen) is bad for the body as a whole, but in the neighborhood where infection-fighting antibodies arise, may be important for keeping proper order. Read More

Terunaga Nakagawa, with colleagues from Japan and Oxford University in England, has discovered the bridgelike molecular structure of a mysterious glutamate receptor. Read More

Tuberculosis (TB) remains an important public health problem, particularly among people infected with the human immunodeficiency virus (HIV). Read More

The 2C-subtype of the serotonin receptor (5HT2C), which binds the neurotransmitter serotonin, plays an important role in regulating food intake and metabolism. Read More

Vanderbilt University researcher Danny Winder, Ph.D., has received a MERIT Award from the National Institute of Alcohol Abuse and Addiction (NIAAA), part of the National Institutes of Health, for his contributions to understanding how alcohol affects the brain. Read More

Women may be at higher risk than men when it comes to overuse of opioid-containing painkillers, speakers warned at a research symposium at Vanderbilt University Medical Center earlier this month. Read More

A new method developed at Vanderbilt may help “inventory” all tumor-promoting genes. Read More

Drugs that are being used clinically to treat obesity and diabetes may also have a role in treating drug abuse. Read More

New studies of a membrane transporter could explain antibiotic resistance – and lead to novel ways to combat it. Read More

The risks of taking opioids during pregnancy or to manage chronic pain, and the impact this frequently prescribed class of pain relievers has on the adolescent brain will be discussed Wednesday, July 13, during a “bedside-to-bench” symposium at Vanderbilt University Medical Center. Read More

Vanderbilt University Medical Center (VUMC) has been chosen by the National Institutes of Health (NIH) to be the Data and Research Support Center for the Precision Medicine Initiative Cohort Program, a landmark study of genetic, environmental and lifestyle factors affecting the health of a million or more people, federal officials have announced. Read More

Many clinical trials are stopped prematurely because they fail to recruit enough study participants. Vanderbilt University Medical Center has received a five-year, $14 million grant from the National Center for Advancing Translational Sciences at the National Institutes of Health to address this. Read More

Researchers at Vanderbilt University Medical Center and Duke Clinical Research Institute have received a major federal grant to study how multisite clinical trials of new drugs and therapies in children and adults can be conducted more rapidly and efficiently. Read More

Imaging with a compound that binds to neuroendocrine cells is a safer and more effective way to detect rare neuroendocrine tumors. Read More